Xora Innovation

Xora Innovation is a venture capital investment firm based in Singapore, established in 2020. The company focuses on early-stage deep tech ventures, aiming to accelerate their path to market. It primarily invests in three key sectors: computing and communications, climate and energy, and artificial intelligence in physical industries. Xora Innovation emphasizes opportunities in Asia and North America, with a particular focus on energy, renewable energy, and biotechnology. By targeting disruptive and transformative deep science ventures, Xora Innovation seeks to support companies that have the potential to create significant global impact.

Sofia Bensily

Senior Associate

Joel Leong

Director, Research and Analytics

Candice Ong

COO and Partner

Hari Ramachandran

Venture Builder

Donna See

CEO

Alan Thompson

Interim CEO

Phoebe Tan Ph.D

Partner

20 past transactions

Summit Nanotech

Venture Round in 2025
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, that specializes in innovative lithium extraction methods aimed at supporting the global energy transition. Founded in 2018, the company has developed a patented direct lithium extraction (DLE) technology that offers a more sustainable and environmentally friendly approach compared to traditional extraction methods. By collaborating with mining companies and lithium asset owners in Chile and Argentina, Summit Nanotech aims to conserve natural resources while optimizing lithium production operations. Its focus on providing cost-effective solutions positions Summit Nanotech as a key player in the lithium supply chain, addressing industry challenges while minimizing environmental impact.

Vsim Technology

Seed Round in 2024
Vsim Technology offers physics simulations technologies for AI, robotics, VFX, research and the industrial metaverse.

HyperLight

Series B in 2024
HyperLight specializes in thin-film lithium niobate photonic integrated circuit solutions, focusing on the development of integrated optical circuits that minimize signal loss. Their product offerings include chip-scale modulators and photonic chips tailored for data centers, datacom, and quantum computing applications. These advanced circuits facilitate the conversion of signals between electricity and light waves, achieving high performance standards that allow clients to operate efficiently at reduced power levels. HyperLight collaborates closely with customers throughout the entire process, from conceptualization and design to prototyping and volume production, ensuring tailored solutions that meet specific needs in the rapidly evolving field of photonics.

Celestial AI

Series C in 2024
Celestial AI is a machine learning accelerator company focused on developing an advanced optical interconnect technology platform for data centers and AI applications. By leveraging photonics, mixed-signal ASICs, and innovative packaging techniques, the company aims to enhance computing performance sustainably. Its proprietary Photonic FabricTM serves as the core technology for creating optically scalable and disaggregated data center computing and memory systems. This technology is designed to enable significant advancements in artificial intelligence, allowing clients to provide superior AI acceleration hardware and software solutions.

Amperesand

Seed Round in 2024
Amperesand operates as a grid infrastructure solution provider.

Aether Fuels

Seed Round in 2023
Aether Fuels is a cutting-edge climate technology firm that seeks to use ground-breaking methods for creating scalable, affordable, and sustainable fuels to decarbonize "hard-to-abate" sectors including aviation and ocean shipping.

Talus Renewables

Series A in 2023
Talus Renewables offers new pathways to chemicals, fertilizers, and fuels with its green ammonia production technology.

Cosmos Innovation

Series A in 2023
Developer of artificial intelligence-driven solar cell technology platform designed to build next-generation cells. The company's platform technology offers perovskite silicon tandem solar cells that are optimized and improved based on data from those that came before and provides mainstream silicon technology that has a combination of materials and processes to reach its fundamental limits, enabling clients with new solar and semiconductor technologies in a fraction of the time and cost, compared to conventional methods.

Automera

Series A in 2023
Automera is engaged in the development of innovative therapeutic methods for drug creation. The company specializes in an autophagy-targeting drug designed to address specific diseases. Utilizing advanced computational chemistry, artificial intelligence, and quantum molecular dynamics, Automera's technology focuses on designing chimeric small molecules. These molecules are engineered to bind simultaneously to autophagy processes and specific disease targets, functioning as natural defense mechanisms against viruses and bacteria. This approach enables clients to identify and develop effective drugs that harness the body's autophagy capabilities.

Allozymes

Series A in 2023
Allozymes is a deep technology company that specializes in ultrahigh-throughput microfluidics technology to enhance enzyme evolution and development. It focuses on creating sensitive and accurate assays for enzymatic reactions, alongside proprietary microfluidic chips and proteomics technologies. By employing molecular biology and process engineering, Allozymes aims to produce pure enzymes tailored for specific applications. This innovative platform enables clients to expedite custom enzyme development and to create novel, sustainable natural products.

Celestial AI

Series B in 2023
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design and innovative features simplify the creation process, while intelligent data integration and a commitment to security ensure reliable results.

Summit Nanotech

Series A in 2023
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, that specializes in innovative lithium extraction methods aimed at supporting the global energy transition. Founded in 2018, the company has developed a patented direct lithium extraction (DLE) technology that offers a more sustainable and environmentally friendly approach compared to traditional extraction methods. By collaborating with mining companies and lithium asset owners in Chile and Argentina, Summit Nanotech aims to conserve natural resources while optimizing lithium production operations. Its focus on providing cost-effective solutions positions Summit Nanotech as a key player in the lithium supply chain, addressing industry challenges while minimizing environmental impact.

Think Bioscience

Seed Round in 2022
Think Bioscience is focused on advancing synthetic biology to enhance the design and assembly of improved medicines. The company utilizes a unique technology that encodes complex molecular objectives into microbial hosts, facilitating the identification, construction, and evolution of small molecules. This innovative approach allows medical researchers to leverage microbes in the drug discovery process, potentially leading to more effective therapeutic solutions. Through its efforts, Think Bioscience aims to transform how medicines are developed and contribute to the future of healthcare.

Summit Nanotech

Series A in 2022
Summit Nanotech Corporation is a cleantech company based in Calgary, Canada, that specializes in innovative lithium extraction methods aimed at supporting the global energy transition. Founded in 2018, the company has developed a patented direct lithium extraction (DLE) technology that offers a more sustainable and environmentally friendly approach compared to traditional extraction methods. By collaborating with mining companies and lithium asset owners in Chile and Argentina, Summit Nanotech aims to conserve natural resources while optimizing lithium production operations. Its focus on providing cost-effective solutions positions Summit Nanotech as a key player in the lithium supply chain, addressing industry challenges while minimizing environmental impact.

SpeQtral

Venture Round in 2021
SpeQtral specializes in developing advanced quantum communication systems, focusing on both fibre- and satellite-based quantum key distribution and post-quantum cryptographic solutions. With a team of experts in quantum science, cryptography, and engineering, the company addresses the significant security challenges posed by the advancements in quantum computing. SpeQtral's technologies leverage the principles of physics to provide security that is resistant to the potential vulnerabilities of current encryption protocols, ensuring future-proof solutions against emerging computational threats. Their offerings enable businesses to establish secure communication networks enhanced by an additional layer of quantum-secured encryption, positioning them well for the impending quantum revolution.

SpeQtral

Series A in 2021
SpeQtral specializes in developing advanced quantum communication systems, focusing on both fibre- and satellite-based quantum key distribution and post-quantum cryptographic solutions. With a team of experts in quantum science, cryptography, and engineering, the company addresses the significant security challenges posed by the advancements in quantum computing. SpeQtral's technologies leverage the principles of physics to provide security that is resistant to the potential vulnerabilities of current encryption protocols, ensuring future-proof solutions against emerging computational threats. Their offerings enable businesses to establish secure communication networks enhanced by an additional layer of quantum-secured encryption, positioning them well for the impending quantum revolution.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in patients with cardiovascular diseases. The firm specifically targets genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor aims to provide innovative solutions that enable healthcare professionals to effectively treat these conditions and improve heart health in affected individuals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.